Draft tadalafil film-coated tablets 2.5 mg, 5 mg, 10 mg and 20 mg product-specific bioequivalence guidance - Revision 1

  • Email
  • Help

Document details

Download document Draft tadalafil film-coated tablets 2.5 mg, 5 mg, 10 mg and 20 mg product-specific bioequivalence guidance - Revision 1
Reference number EMA/CHMP/315234/2014/Rev. 1
Status draft: consultation open
First published 2017-08-03
Last updated 2017-08-03
Consultation start date 2017-08-03
Consultation end date 2017-10-31
Email address for submissions pkwpsecretariat@ema.europa.eu

Summary

This document provides product-specific guidance on the demonstration of the bioequivalence of tadalafil.